Chronic infusion of angiotensin-(1–7) improves insulin resistance and hypertension induced by a high-fructose diet in rats
- 1 February 2009
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 296 (2), E262-E271
- https://doi.org/10.1152/ajpendo.90678.2008
Abstract
The current study was undertaken to determine whether Ang-(1–7) is effective in improving metabolic parameters in fructose-fed rats (FFR), a model of metabolic syndrome. Six-week-old male Sprague-Dawley rats were fed either normal rat chow (control) or the same diet plus 10% fructose in drinking water. For the last 2 wk of a 6-wk period of either diet, control and FFR were implanted with subcutaneous osmotic pumps that delivered Ang-(1–7) (100 ng·kg−1·min−1). A subgroup of each group of animals (control or FFR) underwent a sham surgery. We measured systolic blood pressure (SBP) together with plasma levels of insulin, triglycerides, and glucose. A glucose tolerance test (GTT) was performed, with plasma insulin levels determined before and 15 and 120 min after glucose administration. In addition, we evaluated insulin signaling through the IR/IRS-1/PI3K/Akt pathway as well as the phosphorylation levels of IRS-1 at inhibitory site Ser307 in skeletal muscle and adipose tissue. FFR displayed hypertriglyceridemia, hyperinsulinemia, increased SBP, and an exaggerated release of insulin during a GTT, together with decreased activation of insulin signaling through the IR/IRS-1/PI3K/Akt pathway in skeletal muscle, liver, and adipose tissue, as well as increased levels of IRS-1 phospho-Ser307 in skeletal muscle and adipose tissue, alterations that correlated with increased activation of the kinases mTOR and JNK. Chronic Ang-(1–7) treatment resulted in normalization of all alterations. These results show that Ang-(1–7) ameliorates insulin resistance in a model of metabolic syndrome via a mechanism that could involve the modulation of insulin signaling.Keywords
This publication has 50 references indexed in Scilit:
- The renin–angiotensin–aldosterone system: a pivotal role in insulin sensitivity and glycemic controlCurrent Opinion in Endocrinology, Diabetes and Obesity, 2008
- Myricetin, a naturally occurring flavonol, ameliorates insulin resistance induced by a high-fructose diet in ratsLife Sciences, 2007
- Effect of Inhibition of the Renin-Angiotensin System on Development of Type 2 Diabetes Mellitus (Meta-Analysis of Randomized Trials)The American Journal of Cardiology, 2007
- Angiotensin-(1-7) Through Receptor Mas Mediates Endothelial Nitric Oxide Synthase Activation via Akt-Dependent PathwaysHypertension, 2007
- Irbesartan restores the in-vivo insulin signaling pathway leading to Akt activation in obese Zucker ratsJournal of Hypertension, 2006
- Chronic angiotensin-(1–7) prevents cardiac fibrosis in DOCA-salt model of hypertensionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Angiotensin II Type-1 Receptor Blocker Valsartan Enhances Insulin Sensitivity in Skeletal Muscles of Diabetic MiceHypertension, 2004
- Mammalian target of rapamycin regulates IRS-1 serine 307 phosphorylationBiochemical and Biophysical Research Communications, 2004
- A central role for JNK in obesity and insulin resistanceNature, 2002
- Role of angiotensin II in high fructose-induced left ventricular hypertrophy in rats.Hypertension, 1993